HomeNDC LookupIngredientsHydroxyzine Hydrochloride › 42806-0161-01
Hydroxyzine Hydrochloride 50 mg Tablet, Film Coated, 100-count — NDC 42806-0161-01 package photo

Hydroxyzine Hydrochloride 50 mg Tablet, Film Coated, 100-count

by Epic Pharma, LLC · 100 TABLET, FILM COATED in 1 BOTTLE (42806-161-01)
NDC 42806-0161-01
🏷️ FDA NDC (as labeled) 42806-161-01 billing pads the product segment with a zero
This package
Contains100-count Cost per ea$0.0583 NADAC Per package$5.83 / 100 tablets Pack sizes3 compare ↓
Also priced by: Medicaid pays $0.1936/unit · Part D plans $0.1378/unit — full pricing hub ↓
Rx only Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Hydroxyzine Hydrochloride (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class III · Jun 2, 2026 — Presence of foreign substance (ANI Pharmaceuticals, Inc.) · FDA recall D-0619-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 42806-161-01
Product NDC 42806-161
11-digit billing NDC 42806016101
NCPDP billing unit EA — each (per item)
RxCUI 995218, 995258, 995281
UNII 76755771U3
UPC 0342806160015
Application # ANDA040604
SPL Set ID 82b015dc-999c-46a4-bcaa-a4c81a193b68
Established class (EPC) Antihistamine
Mechanism of action Histamine Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2015-03-31
Route ORAL
Dosage form TABLET, FILM COATED
Substance HYDROXYZINE DIHYDROCHLORIDE
GPI-14 57200040100315
GPI class hydrOXYzine HCl
GCN Seq No 003729
GCN 13944
HICL code 001608
Ingredient (HICL) Hydroxyzine Hcl
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2P
Therapeutic class — specific (HIC3) Antihistamines - 1St Generation
AHFS code 04:04.00.00
AHFS class First Generation Antihistamines
FDB label name HYDROXYZINE HCL 50 MG TABLET
FDB brand name Hydroxyzine Hcl
Legend status F — Federal legend — prescription drug or device
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 42806-161-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 42806-0161-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Antihistamine class.

Pharmacologic class Antihistamine
Drug family (ATC) Diphenylmethane derivatives
How it works Histamine Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerEpic Pharma, LLC
Application holderEPIC PHARMA LLC
FDA applicationANDA040604 (ANDA)
Labeler code42806
First marketedMar 2015
Product typeHuman Prescription Drug
Portfolio171 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name HYDROXYZINE HCL 50 MG TABLET Ingredient Hydroxyzine Hcl
📖 What it is MedlinePlus · NLM

Hydroxyzine is used to relieve itching caused by allergic skin reactions, to relieve anxiety and tension, and as a sedative before and after general anesthesia for surgery. Hydroxyzine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. It also works by decreasing activity in the brain.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Hydroxyzine is most often used to relieve anxiety and tension, or to control itching from allergic conditions like hives or eczema. It's also used as a calming medication before su...
  • Drowsiness is the most common side effect — it's actually how the medication works, so some sleepiness is expected, especially when you first start. For most people it gets better...
  • This is really important to go over with your pharmacist or doctor, because hydroxyzine interacts with a number of common drugs. Combining it with alcohol, opioid pain medicines, s...
  • Can I take hydroxyzine with my other medications?
📖 Read our full Hydroxyzine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color orange / green / yellow
ShapeRound
Imprint161
Size9 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII R12CBM0EIZ
    A natural wax derived from a Brazilian palm tree, used as a coating and polish on tablets and capsules. It creates a smooth, shiny finish that protects the medicine and improves appearance.
  • UNII 2S7830E561
    Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII 532B59J990
    Polyvinyl alcohol is a synthetic polymer made from plant-derived materials. It's used as a binder to hold ingredients together, a film-former in coatings, and a thickener in liquid formulations.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII XHX3C3X673
    Triacetin is a clear, oily liquid made from glycerin and acetic acid. It works as a plasticizer and solvent in medicines, helping soften coatings and improve how liquids mix together in formulations.

15 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.058 $5.83 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.1936 $19.36 / 100 tablets
Medicare drug plans payPart D · Q2 2026 $0.1378 $13.78 / 100 tablets
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Jul 2022 Dec 2025 Aug 2026 $0.096 $0.058
▼ Down 14% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Hydroxyzine Hydrochloride 50 mg 00093-5062-01 Teva 100 tablets $0.058 AB Availability likely
Hydroxyzine Hydrochloride 50 mg 00904-6618-61 Major 1 tablet $0.058 AB Availability likely
Hydroxyzine hydrochloride 50 mg 00904-7379-40 Major 500 tablets $0.058 AB Availability likely
Hydroxyzine Hydrochloride 50 mg 16571-0115-01 Rising 100 tablets $0.058 AB Availability likely
HydrOXYzine Hydrochloride 50 mg 16714-0083-10 Northstar 100 tablets $0.058 AB Availability likely
Hydroxyzine hydrochloride 50 mg 23155-0502-01 Heritage 100 tablets $0.058 AB Availability likely
Hydroxyzine Hydrochloride 50 mg 24658-0783-10 PURACAP 1000 tablets $0.058 AB Availability likely
Hydroxyzine Hydrochloride 50 mgthis 42806-0161-01 Epic 100 tablets $0.058 AB Availability likely
Hydroxyzine Hydrochloride 50 mg 59651-0501-01 Aurobindo 100 tablets $0.058 Availability likely
Hydroxyzine Hydrochloride 50 mg 60687-0875-01 American 1 tablet $0.058 AB Availability likely
Hydroxyzine Hydrochloride 50 mg 62135-0575-05 Chartwell 500 tablets $0.058 AB Availability likely
Hydroxyzine Hydrochloride 50 mg 10702-0012-01 KVK-Tech, 100 tablets $0.068 AB FDA listed +17%
Hydroxyzine hydrochloride 50 mg 00615-8564-39 NCS 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 10135-0812-01 Marlex 100 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 11534-0206-01 Sunrise 100 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 31722-0502-01 Camber 100 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 43063-0519-30 PD-Rx 30 tablets FDA listed
Hydroxyzine hydrochloride 50 mg 43063-0779-30 PD-Rx 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 43063-0963-01 PD-Rx 100 tablets FDA listed
HydrOXYzine Hydrochloride 50 mg 50090-2614-00 A-S 100 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 50090-6293-01 A-S 30 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 51407-0971-10 Golden 1000 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 51655-0119-52 Northwind 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 51655-0467-52 Northwind 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 62135-0547-05 Chartwell 500 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 63187-0354-15 Proficient 15 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 63629-4929-01 Bryant 120 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 65162-0577-10 Amneal 100 tablets FDA listed
HydrOXYzine Hydrochloride 50 mg 67296-2224-01 Redpharm 10 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 68071-5133-03 NuCare 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 68071-5291-03 NuCare 30 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 70518-1265-01 REMEDYREPACK 60 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 70518-4170-00 REMEDYREPACK 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 71205-0083-15 Proficient 15 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 71205-0332-15 Proficient 15 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 71335-0246-01 Bryant 120 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 71335-2185-01 Bryant 120 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 71335-2410-01 Bryant 120 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 71335-3036-01 Bryant 1000 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 72162-2167-00 Bryant 1000 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 72162-2513-00 Bryant 1000 tablets AB FDA listed
Hydroxyzine HCL 50 mg 72189-0577-60 Direct_rx 60 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 72789-0269-30 PD-Rx 30 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 72789-0378-30 PD-Rx 30 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 76420-0883-01 Asclemed 100 tablets AB FDA listed
Hydroxyzine HCL 50 mg 80425-0173-01 Advanced 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 80425-0376-01 Advanced 30 tablets AB FDA listed
Hydroxyzine Hydrochloride 50 mg 80425-0394-01 Advanced 30 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 87441-0039-01 Unit 30 tablets AB FDA listed
Hydroxyzine hydrochloride 50 mg 70518-0487-01 REMEDYREPACK 90 tablets AB Discontinued
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2015
On the market since
Mar 2015
📍
2026
Currently FDA-listed
11 years listed
🔓
·
Generic on the market
this product is a generic
This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 42806-0161-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
12.1K
Units reimbursed last 4 qtrs
738.8K
Gross reimbursed last 4 qtrs
$143K
Avg / prescription
$11.83
Avg / unit
$0.1936
Latest quarter Q4 2025
952Rx
Medicaid pays / ea
$0.1936
gross reimbursed
vs
NADAC / ea
$0.0583
acquisition cost
=
Spread
+$0.1353
+232% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
52% FFS 48% MCO
Fee-for-service · 6,255 Rx Managed care · 5,834 Rx
State Medicaid map
Alaska: 685 units · 93.5 per 100k residents AK Maine: 1,960 units · 141 per 100k residents ME Washington: 51,914 units · 665 per 100k residents WA Idaho: 2,339 units · 119 per 100k residents ID Montana: 1,030 units · 91.0 per 100k residents MT North Dakota: no data reported ND Minnesota: 3,640 units · 63.4 per 100k residents MN Wisconsin: 3,248 units · 55.0 per 100k residents WI Michigan: 13,126 units · 131 per 100k residents MI New York: 100,100 units · 511 per 100k residents NY Vermont: 2,395 units · 370 per 100k residents VT New Hampshire: 14,253 units · 1,017 per 100k residents NH Oregon: 20,880 units · 493 per 100k residents OR Nevada: 2,932 units · 91.8 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 894 units · 27.9 per 100k residents IA Illinois: 4,091 units · 32.6 per 100k residents IL Indiana: 2,499 units · 36.4 per 100k residents IN Ohio: 7,094 units · 60.2 per 100k residents OH Pennsylvania: 108,329 units · 836 per 100k residents PA New Jersey: 20,031 units · 216 per 100k residents NJ Massachusetts: 6,161 units · 88.0 per 100k residents MA California: 194,311 units · 499 per 100k residents CA Utah: 2,332 units · 68.2 per 100k residents UT Colorado: 2,070 units · 35.2 per 100k residents CO Nebraska: 1,062 units · 53.7 per 100k residents NE Missouri: 10,129 units · 163 per 100k residents MO Kentucky: 7,477 units · 165 per 100k residents KY West Virginia: 2,031 units · 115 per 100k residents WV Virginia: 18,968 units · 218 per 100k residents VA Maryland: 28,453 units · 460 per 100k residents MD Connecticut: 3,839 units · 106 per 100k residents CT Rhode Island: no data reported RI Arizona: 3,547 units · 47.7 per 100k residents AZ New Mexico: 2,915 units · 138 per 100k residents NM Kansas: 585 units · 19.9 per 100k residents KS Arkansas: 2,790 units · 91.0 per 100k residents AR Tennessee: 4,955 units · 69.5 per 100k residents TN North Carolina: 4,966 units · 45.8 per 100k residents NC South Carolina: 1,040 units · 19.4 per 100k residents SC Delaware: 7,787 units · 755 per 100k residents DE Oklahoma: 8,053 units · 199 per 100k residents OK Louisiana: 17,472 units · 382 per 100k residents LA Mississippi: 1,544 units · 52.5 per 100k residents MS Alabama: 1,146 units · 22.4 per 100k residents AL Georgia: 9,735 units · 88.3 per 100k residents GA D.C.: no data reported DC Hawaii: 1,808 units · 126 per 100k residents HI Texas: 21,133 units · 69.3 per 100k residents TX Florida: 5,900 units · 26.1 per 100k residents FL
Units reimbursed · per 100k residents
19.41,017
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New Hampshire 1,017 /100k
2 Pennsylvania 836 /100k
3 Delaware 755 /100k
4 Washington 665 /100k
5 New York 511 /100k
6 California 499 /100k
7 Oregon 493 /100k
8 Maryland 460 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
500 tablets42806-0161-05 14,561 Rx · $176,873
100 tablets this page42806-0161-01 12,089 Rx · $143,021
1000 tablets42806-0161-10 No Medicaid data
Drug total (last 4 qtrs): 26,650 Rx · 1,585,918 units · $319,894 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
42806-0161-01 You're viewing this 100 TABLET, FILM COATED in 1 BOTTLE (42806-161-01) $0.0583 / ea $5.83 2015-03-31 Active
42806-0161-05 500 TABLET, FILM COATED in 1 BOTTLE (42806-161-05) $0.0583 / ea $29.16 2015-03-31 Active
42806-0161-10 1000 TABLET, FILM COATED in 1 BOTTLE (42806-161-10) $0.0583 / ea $58.31 2015-03-31 Active

You're viewing the smallest of 3 pack sizes for this product.

This pack has the lowest per-ea cost of the 3 priced pack sizes ($0.0583 NADAC).

This pack accounts for about 45% of this product's recent Medicaid fills; most go to the 500 tablets pack. See all packs ↓

Pack size FAQ

What quantity is in NDC 42806-0161-01?
NDC 42806-0161-01 is a 100-count package — 100 tablet, film coated in 1 bottle.
What is the difference between NDC 42806-0161-01 and NDC 42806-0161-05?
Both are Hydroxyzine Hydrochloride 50 mg Tablet, Film Coated — the drug itself is identical. NDC 42806-0161-01 is the 100-count package, while NDC 42806-0161-05 is the 500 tablets package.
What NDC number is used to bill for this package of Hydroxyzine Hydrochloride 50 mg Tablet, Film Coated?
Bill NDC 42806-0161-01 — the 11-digit billing format is 42806016101. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 155 words

INDICATIONS AND USAGE For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus. As a sedative when used as a premedication and following general anesthesia, hydroxyzine may potentiate meperidine and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis.

Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. The effectiveness of hydroxyzine as an antianxiety agent for long term use, that is more than 4 months, has not been assessed by systematic clinical studies.

The physician should reassess periodically the usefulness of the drug for the individual patient.

⏱️ Dosage and Administration 165 words

DOSAGE AND ADMINISTRATION For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested: adults, 50 to 100 mg q.i.d.; children under 6 years, 50 mg daily in divided doses; children over 6 years, 50 to 100 mg daily in divided doses. For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus: adults, 25 mg t.i.d. or q.i.d.; children under 6 years, 50 mg daily in divided doses; children over 6 years, 50 to 100 mg daily in divided doses.

As a sedative when used as a premedication and following general anesthesia: 50 to 100 mg for adults and 0.6 mg/kg of body weight in children. When treatment is initiated by the intramuscular route of administration, subsequent doses may be administered orally. As with all potent medication, the dosage should be adjusted according to the patient's response to therapy.

Contraindications 104 words

CONTRAINDICATIONS Oral hydroxyzine hydrochloride is contraindicated in patients with known hypersensitivity to hydroxyzine hydrochloride products, and in patients with known hypersensitivity to cetirizine hydrochloride or levocetirizine hydrochloride. Hydroxyzine is contraindicated in patients with a prolonged QT interval. Hydroxyzine, when administered to the pregnant mouse, rat, and rabbit induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range.

Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy. Hydroxyzine is contraindicated for patients who have shown a previous hypersensitivity to any component of this medication.

⚠️ Warnings 29 words

WARNINGS Nursing Mothers It is not known whether this drug is excreted in human milk. Since many drugs are so excreted, hydroxyzine should not be given to nursing mothers.

🤒 Adverse Reactions 128 words

ADVERSE REACTIONS Side effects reported with the administration of hydroxyzine hydrochloride are usually mild and transitory in nature. Anticholinergic: Dry mouth. Central Nervous System: Drowsiness is usually transitory and may disappear in a few days of continued therapy or upon reduction of dose.

Involuntary motor activity including rare instances of tremor and convulsions have been reported, usually with doses considerably higher than those recommended. Clinically significant respiratory depression has not been reported at recommended doses. Cardiac System: QT prolongation, Torsade de Pointes.

In postmarketing experience, the following additional undesirable effects have been reported: Body as a Whole: Allergic reaction. Nervous System: Headache. Psychiatric: Hallucination.

Skin and Appendages: Oral hydroxyzine hydrochloride is associated with Acute Generalized Exanthematous Pustulosis (AGEP) and fixed drug eruptions in postmarketing reports. Pruritus, rash, urticaria.

🧓 Geriatric Use 142 words

Geriatric Use A determination has not been made whether controlled clinical studies of hydroxyzine included sufficient numbers of subjects aged 65 and over to define a difference in response from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy.

The extent of renal excretion of hydroxyzine has not been determined. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selections. Sedating drugs may cause confusion and over sedation in the elderly; elderly patients generally should be started on low doses of hydroxyzine and observed closely.

🆘 Overdosage 174 words

OVERDOSAGE The most common manifestation of hydroxyzine overdosage is hypersedation. Other reported signs and symptoms were convulsions, stupor, nausea and vomiting. As in the management of overdosage with any drug, it should be borne in mind that multiple agents may have been taken.

If vomiting has not occurred spontaneously, it should be induced. Immediate gastric lavage is also recommended. General supportive care, including frequent monitoring of the vital signs and close observation of the patient, is indicated.

Hypotension, though unlikely, may be controlled with intravenous fluids and levarterenol or metaraminol. Do not use epinephrine as hydroxyzine counteracts its pressor action. Hydroxyzine overdose may cause QT prolongation and Torsade de Pointes.

ECG monitoring is recommended in cases of hydroxyzine overdose. There is no specific antidote. It is doubtful that hemodialysis would be of any value in the treatment of overdosage with hydroxyzine.

However, if other agents such as barbiturates have been ingested concomitantly, hemodialysis may be indicated. There is no practical method to quantitate hydroxyzine in body fluids or tissue after its ingestion or administration

🧬 Clinical Pharmacology 130 words

CLINICAL PHARMACOLOGY Hydroxyzine hydrochloride is unrelated chemically to the phenothiazines, reserpine, meprobamate or the benzodiazepines. Hydroxyzine is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system. Primary skeletal muscle relaxation has been demonstrated experimentally.

Bronchodilator activity, and antihistaminic and analgesic effects have been demonstrated experimentally and confirmed clinically. An antiemetic effect, both by the apomorphine test and the veriloid test, has been demonstrated. Pharmacological and clinical studies indicate that hydroxyzine in therapeutic dosage does not increase gastric secretion or acidity and in most cases has mild antisecretory activity.

Hydroxyzine is rapidly absorbed from the gastrointestinal tract and hydroxyzine’s clinical effects are usually noted within 15 to 30 minutes after oral administration.

📦 How Supplied / Storage and Handling 162 words

HOW SUPPLIED Hydroxyzine Hydrochloride Tablets USP, 10 mg are available as 9/32", Orange round biconvex film-coated tablets, debossed “Є” above “159” on one side and plain on the other side, packaged in bottles of 100’s, 500’s and 1000’s. Hydroxyzine Hydrochloride Tablets USP, 25 mg are available as 10/32", Green round biconvex film-coated tablets debossed “Є” above “160” on one side and plain on the other side, packaged in bottles of 100’s, 500’s and 1000’s. Hydroxyzine Hydrochloride Tablets USP, 50 mg are available as 11/32", Yellow round biconvex film-coated tablets, debossed “Є” above “161” on one side and plain on the other side, packaged in bottles of 100’s, 500’s and 1000’s.

Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure, as required. Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Manufactured by: Epic Pharma, LLC Laurelton, NY 11413 Manufactured in USA Rev. 01-2023-00 MF159REV01/23 OE1518

📋 Description 122 words

DESCRIPTION Hydroxyzine hydrochloride, USP has the chemical name of 2-[2-[4-( p -Chloro-α-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol dihydrochloride. C 21 H 27 CIN 2 O 2 ·2HCl M.W. 447.83 Hydroxyzine hydrochloride, USP occurs as a white, odorless powder which is very soluble in water.

Each tablet for oral administration contains 10 mg, 25 mg or 50 mg hydroxyzine hydrochloride, USP. Inactive ingredients include carnauba wax, colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose, D&C Yellow #10 Aluminum Lake (25 mg and 50 mg), FD&C Blue #2 Aluminum Lake (25 mg), FD&C Red #40 Aluminum Lake (50 mg), FD&C Yellow #6 Aluminum Lake (10 mg and 50 mg), hypromellose, polyethylene glycol 3350, polyvinyl alcohol, talc, titanium dioxide, triacetin and yellow iron oxide (10 mg).

Structural Formula

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.